Expects to maintain "mid-threes" debt/EBITDA ratio over next few years. Expects "modest" share repurchases in 2024/2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on CVS: